Validation of an Acute Ischemic Stroke Model
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 38 (6), 1820-1825
- https://doi.org/10.1161/strokeaha.106.479154
Abstract
Background and Purpose— Prediction models for ischemic stroke outcome have the potential to contribute prognostic information in the clinical and/or research setting. The importance of diffusion-weighted magnetic resonance imaging (DWI) in the prediction of clinical outcome, however, is unclear. The purpose of this study was to combine acute clinical data and DWI lesion volume for ischemic stroke patients to determine whether DWI improves the prediction of clinical outcome. Methods— Patients (N=382) with baseline DWI data from the Glycine Antagonist In Neuroprotection and citicoline (010 and 018) trials were used to develop the prediction models by multivariable logistic regression. Data from prospectively collected patients (N=266) from the Acute Stroke Accurate Prediction Study were used to externally validate the model equations. The models predicted either full recovery or nursing home-level disability/death, as defined by the National Institutes of Health Stroke Scale, Barthel Index, or modified Rank...Keywords
This publication has 16 references indexed in Scilit:
- Relationship between 3-Month National Institutes of Health Stroke Scale Score and Dependence in Ischemic Stroke PatientsNeuroepidemiology, 2006
- MR diffusion-weighted imaging and outcome prediction after ischemic strokeNeurology, 2006
- Predicting Long-Term Independency in Activities of Daily Living After Middle Cerebral Artery StrokeStroke, 2006
- Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territoryJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Risk Adjustment Effect on Stroke Clinical TrialsStroke, 2004
- Predicting Outcome in Ischemic StrokeStroke, 2003
- Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke?Neurology, 2002
- Glycine Antagonist in Neuroprotection for Patients With Acute StrokeJAMA, 2001
- Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trialThe Lancet, 2000
- Predicting Outcome From Hypoxic-lschemic ComaJAMA, 1985